Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Prenatal And Newborn Genetic Testing Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The prenatal and newborn genetic testing market has seen substantial expansion in recent years. Its valuation is anticipated to increase from $6.68 billion in 2024 to $7.6 billion in 2025, achieving a compound annual growth rate (CAGR) of 13.7%. This historical expansion can be attributed to enhancements in non-invasive prenatal testing, a rise in maternal age, supportive governmental and healthcare policies, and patient desire for early detection.
The prenatal and newborn genetic testing market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $12.07 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.3%. Factors contributing to this growth during the forecast period include the broadening of genetic test panels, increased awareness regarding maternal health, established prenatal and newborn screening protocols, a heightened emphasis on rare diseases, and evolving ethical and regulatory frameworks. Key trends anticipated during the forecast timeframe encompass non-invasive prenatal testing (NIPT), whole genome sequencing (WGS) and whole exome sequencing, the incorporation of artificial intelligence (AI), preimplantation genetic testing (PGT), and direct-to-consumer genetic testing.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp
Which Drivers Are Shaping The Prenatal And Newborn Genetic Testing Industry’s Market Share?
Future expansion of the prenatal and newborn genetic testing markets is anticipated due to government programs and assistance for prenatal testing and newborn genetic screening. These initiatives encompass particular actions, programs, policies, or projects executed by governmental bodies at local, regional, or national tiers, aimed at resolving issues, accomplishing objectives, or fostering public welfare. Specifically, government efforts in prenatal and newborn genetic testing aid the population by facilitating the detection of genetic conditions or abnormalities in fetuses during gestation or in infants soon after delivery. An example of this is the Australian government’s annual commitment of $1.3 million in June 2022 to the New South Wales (NSW), a state on Australia’s east coast, newborn screening program. This funding provides complimentary tests for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), encompassing newborn genetic testing and screening, for all infants born in the state. Approximately 100,000 babies are expected to receive these screening tests annually, potentially saving the lives of up to 13 newborns who might otherwise suffer from these genetic conditions. Consequently, government initiatives and backing for prenatal testing and newborn genetic screening are key drivers for the prenatal and newborn genetic testing markets.
What Are The Major Segment Types Covered In The Prenatal And Newborn Genetic Testing Market?
The prenatal and newborn genetic testingmarket covered in this report is segmented –
1) By Product Type: Consumables; Instruments
2) By Screening: Non-Invasive Prenatal Testing; Chronic Villus Sampling; Amniocentesis; Maternal Serum Screening; Other Screenings
3) By Disease: Down Syndrome; Phenylketonuria; Cystic Fibrosis; Sickle Cell Anemia
4) By End User: Hospital; Maternity And Specialty Clinics; Diagnostic Centers
Subsegments:
1) By Consumables: Reagents And Assays; Sample Collection Kits; Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines; Sequencers; Microarray Analyzers
What Key Innovation Trends Are Fueling Advancements In The Prenatal And Newborn Genetic Testing Market?
Leading firms in the prenatal and newborn genetic testing sectors are prioritizing the creation of cutting-edge screening methods, such as noninvasive prenatal screening, that offer enhanced accessibility and cost-effectiveness to deliver dependable services to consumers. Noninvasive prenatal screening (NIPS), also known as noninvasive prenatal testing (NIPT), represents a sophisticated and secure genetic screening technique utilized during gestation to evaluate the likelihood of particular fetal chromosomal irregularities. An example of this is Juno Diagnostics Inc., a US-based healthcare technology company, which introduced Juno Hazel in November 2022. This noninvasive prenatal screening test is designed to identify chromosomal aberrations and deliver relevant clinical information. This test utilizes a sample collection kit, thereby removing the necessity for phlebotomy and enhancing its overall accessibility. Furthermore, the company intends to provide educational materials and individualized genetic counseling assistance through collaborations with physicians and genetic counselors.
Which Key Market Players Are Investing In Expansion And Innovation Of Prenatal And Newborn Genetic Testing Market?
Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Prenatal And Newborn Genetic Testing Market During The Forecast Period?
North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Prenatal And Newborn Genetic Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp
Browse Through More Reports Similar to the Global Prenatal And Newborn Genetic Testing Market 2025, By The Business Research Company
Endotoxin Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/endotoxin-testing-global-market-report
Heavy Metal Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/heavy-metal-testing-global-market-report
5G Device Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/5g-device-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model